Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PEOPLE - Sequenom makes appointment:

This article was originally published in Clinica

Executive Summary

Sequenom (San Diego, California), a developer of genetic analysis products, has appointed Steven Owings as vice president of commercial development. The priority focus of this newly-created position is commercialisation of the firm's first noninvasive pre-natal test. Mr Owings' 28 years in the diagnostics and biotech fields include stints at Roche Diagnostic Systems, Digene and Visible Genetics (part of Bayer Diagnostics since 2002). He joins from molecular diagnostics company Primagen (Georgia), where he was president of the North America division.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT047586

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel